Nutex Health Reports Officer/Director Changes & Compensation
Ticker: NUTX · Form: 8-K · Filed: Sep 22, 2025 · CIK: 1479681
Sentiment: neutral
Topics: officer-changes, director-changes, compensation, regulation-fd
Related Tickers: NUTX
TL;DR
Nutex Health shake-up: new officers, director changes, and pay details filed.
AI Summary
Nutex Health, Inc. filed an 8-K on September 22, 2025, reporting events that occurred on September 16, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
Changes in key personnel and compensation arrangements can signal shifts in company strategy or financial health, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in officers and directors, especially if numerous or unexpected, can indicate internal instability or strategic realignments that carry inherent risks.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- September 16, 2025 (date) — Earliest event date
- September 22, 2025 (date) — Report date
- Delaware (jurisdiction) — State of Incorporation
- Houston, Texas (location) — Business and Mail Address
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the names or exact positions affected within this summary.
Are the compensatory arrangements mentioned related to new hires, departures, or existing officers?
The filing mentions "Compensatory Arrangements of Certain Officers" but does not provide specific details on whether these relate to new appointments, departures, or ongoing compensation within this summary.
Does the filing provide any financial statements or exhibits related to the reported changes?
Yes, the filing explicitly lists "Financial Statements and Exhibits" as an item information category.
What is the significance of the 'Regulation FD Disclosure' item?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, suggesting this filing may contain such information.
What was Nutex Health, Inc.'s former name?
Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
Filing Stats: 1,275 words · 5 min read · ~4 pages · Grade level 10.9 · Accepted 2025-09-22 09:39:45
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value NUTX NASDAQ Capital Market
- $415,000 — tled to receive a base annual salary of $415,000, subject to annual review by the Compan
- $100,000 — eive an additional cash compensation of $100,000 as a signing bonus, payable in four equ
- $25,000 — ble in four equal quarterly payments of $25,000, provided Mr. Bamburg remains in employ
Filing Documents
- nutx-20250916.htm (8-K) — 32KB
- ex101-bamburgemploymentagr.htm (EX-10.1) — 156KB
- ex991-bamburgpr.htm (EX-99.1) — 10KB
- 0001479681-25-000083.txt ( ) — 351KB
- nutx-20250916.xsd (EX-101.SCH) — 2KB
- nutx-20250916_lab.xml (EX-101.LAB) — 22KB
- nutx-20250916_pre.xml (EX-101.PRE) — 13KB
- nutx-20250916_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. A copy of the Company's press release announcing Mr. Bamburg's appointment is furnished with this Current Report on Form 8-K as Exhibit 99.1. The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 10.1 Employment Agreement, executed as of September 16, 2025 between the Company and We sl ey Bamburg 99.1 Press Release dated September 22, 2025 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: September 22, 2025 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer